Literature DB >> 35332513

Blood Pressure in Acute Stroke and Secondary Stroke Prevention.

Christopher R Green1, J Claude Hemphill2.   

Abstract

PURPOSE OF REVIEW: Hypertension is common in patients presenting with stroke and is independently associated with unfavorable outcomes. This article reviews current guidelines for early management of blood pressure (BP) and highlights the findings of recent investigative works. RECENT
FINDINGS: Intensive blood pressure reduction after receiving alteplase has not been shown to improve outcomes. Patients with large vessel occlusions may benefit from lower blood pressure targets post-intervention. Retrospective analyses of large intracerebral hemorrhage trials suggest that specific subgroups of patients may disproportionately benefit from or be harmed by intensive BP reduction. Robust data for management of blood pressure in subarachnoid hemorrhage patients is lacking and expert consensus continues to guide decision-making. Despite the impact of hypertension on outcomes, most prospective trials assessing efficacy of blood pressure reduction have yielded neutral or inconclusive results. Further trials are necessary to determine which patient populations are most likely to benefit from blood pressure control.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acute ischemic stroke; Blood pressure; Endovascular therapy; Intracerebral hemorrhage; Subarachnoid hemorrhage; Tissue plasminogen activator

Mesh:

Substances:

Year:  2022        PMID: 35332513     DOI: 10.1007/s11910-022-01169-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  41 in total

Review 1.  Global Burden of Stroke.

Authors:  Valery L Feigin; Bo Norrving; George A Mensah
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

2.  Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

Authors:  Craig S Anderson; Yining Huang; Richard I Lindley; Xiaoying Chen; Hisatomi Arima; Guofang Chen; Qiang Li; Laurent Billot; Candice Delcourt; Philip M Bath; Joseph P Broderick; Andrew M Demchuk; Geoffrey A Donnan; Alice C Durham; Pablo M Lavados; Tsong-Hai Lee; Christopher Levi; Sheila O Martins; Veronica V Olavarria; Jeyaraj D Pandian; Mark W Parsons; Octavio M Pontes-Neto; Stefano Ricci; Shoichiro Sato; Vijay K Sharma; Federico Silva; Lili Song; Nguyen H Thang; Joanna M Wardlaw; Ji-Guang Wang; Xia Wang; Mark Woodward; John Chalmers; Thompson G Robinson
Journal:  Lancet       Date:  2019-02-07       Impact factor: 79.321

3.  Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States.

Authors:  Adnan I Qureshi; Mustapha A Ezzeddine; Abu Nasar; M Fareed K Suri; Jawad F Kirmani; Haitham M Hussein; Afshin A Divani; Alluru S Reddi
Journal:  Am J Emerg Med       Date:  2007-01       Impact factor: 2.469

Review 4.  Factors affecting clinical outcome in large-vessel occlusive ischemic strokes.

Authors:  Michelle P Lin; Georgios Tsivgoulis; Andrei V Alexandrov; Jason J Chang
Journal:  Int J Stroke       Date:  2014-12-03       Impact factor: 5.266

5.  Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome.

Authors:  José Castillo; Rogelio Leira; María M García; Joaquín Serena; Miguel Blanco; Antoni Dávalos
Journal:  Stroke       Date:  2004-01-15       Impact factor: 7.914

Review 6.  The management of hypertension for an acute stroke: what is the blood pressure goal?

Authors:  Philip B Gorelick; Venkatesh Aiyagari
Journal:  Curr Cardiol Rep       Date:  2013-06       Impact factor: 2.931

7.  U-shaped relationship between mortality and admission blood pressure in patients with acute stroke.

Authors:  K N Vemmos; G Tsivgoulis; K Spengos; N Zakopoulos; A Synetos; E Manios; P Konstantopoulou; M Mavrikakis
Journal:  J Intern Med       Date:  2004-02       Impact factor: 8.989

8.  Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).

Authors:  Niaz Ahmed; Nils Wahlgren; Michael Brainin; José Castillo; Gary A Ford; Markku Kaste; Kennedy R Lees; Danilo Toni
Journal:  Stroke       Date:  2009-05-21       Impact factor: 7.914

9.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  William J Powers; Alejandro A Rabinstein; Teri Ackerson; Opeolu M Adeoye; Nicholas C Bambakidis; Kyra Becker; José Biller; Michael Brown; Bart M Demaerschalk; Brian Hoh; Edward C Jauch; Chelsea S Kidwell; Thabele M Leslie-Mazwi; Bruce Ovbiagele; Phillip A Scott; Kevin N Sheth; Andrew M Southerland; Deborah V Summers; David L Tirschwell
Journal:  Stroke       Date:  2019-10-30       Impact factor: 7.914

10.  Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.

Authors:  Salim S Virani; Alvaro Alonso; Hugo J Aparicio; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Susan Cheng; Francesca N Delling; Mitchell S V Elkind; Kelly R Evenson; Jane F Ferguson; Deepak K Gupta; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Chong D Lee; Tené T Lewis; Junxiu Liu; Matthew Shane Loop; Pamela L Lutsey; Jun Ma; Jason Mackey; Seth S Martin; David B Matchar; Michael E Mussolino; Sankar D Navaneethan; Amanda Marma Perak; Gregory A Roth; Zainab Samad; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Andrew Stokes; Lisa B VanWagner; Nae-Yuh Wang; Connie W Tsao
Journal:  Circulation       Date:  2021-01-27       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.